Jefferies Initiates Auris Medical With Buy
Analysts at Jefferies initiated coverage on shares of Auris Medical (NASDAQ: EARS) with a Buy rating.
The target price for Auris Medical is set to $12.
Auris Medical's shares gained 0.82% to close at $6.15 on Friday.
Latest Ratings for EARS
Date | Firm | Action | From | To |
---|---|---|---|---|
Apr 2017 | Roth Capital | Initiates Coverage On | Buy | |
Mar 2016 | Jefferies | Maintains | Buy | |
Sep 2014 | Needham | Initiates Coverage On | Buy |
View More Analyst Ratings for EARS
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: JefferiesInitiation Analyst Ratings